← Back to Clinical Trials
Recruiting NCT06960772

NCT06960772 Efficacy of Flow Ball Phonation in Professional Voice Users

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06960772
Status Recruiting
Phase
Sponsor University Ghent
Condition Prevention of Voice Disorders in Professional Voice Users
Study Type INTERVENTIONAL
Enrollment 144 participants
Start Date 2025-05-08
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Flow Ball InterventionStraw Phonation InterventionSham Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 144 participants in total. It began in 2025-05-08 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to investigate the effects of flow ball phonation on the voice of professional voice users and elite vocal performers, both with and without functional voice disorders. Given the substantial vocal demands inherent to this population and their reliance on the voice for occupational purposes, this intervention may represent a valuable approach for the prevention and/or treatment voice disorders.

Eligibility Criteria

OBJECTIVE 1: TREATMENT Inclusion Criteria: * All genders * All ethnicities * 18 - 60 years * Diagnosis of a functional voice disorder * Professional voice users Exclusion Criteria: * Diagnosis of an organic voice disorder * Current participation in voice therapy * Previous phonosurgical interventions * Pregnancy * Smoking * Nasal or ear diseases * Neurological disorders OBJECTIVE 2: PREVENTION Inclusion Criteria: * All genders * All ethnicities * 18 - 60 years * Professional voice users Exclusion Criteria: * Current or previous diagnosis of a voice disorder * Current or previous participation in voice therapy * Previous phonosurgical interventions * Pregnancy * Smoking * Nasal or ear diseases * Neurological disorders

Contact & Investigator

Central Contact

Casey Dewanckele

✉ casey.dewanckele@ugent.be

📞 +32491547192

Principal Investigator

Evelien D'haeseleer

PRINCIPAL INVESTIGATOR

University Ghent

Frequently Asked Questions

Who can join the NCT06960772 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Prevention of Voice Disorders in Professional Voice Users. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06960772 currently recruiting?

Yes, NCT06960772 is actively recruiting participants. Contact the research team at casey.dewanckele@ugent.be for enrollment information.

Where is the NCT06960772 trial being conducted?

This trial is being conducted at Ghent, Belgium.

Who is sponsoring the NCT06960772 clinical trial?

NCT06960772 is sponsored by University Ghent. The principal investigator is Evelien D'haeseleer at University Ghent. The trial plans to enroll 144 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology